PT-141 (Bremelanotide): Mechanism, FDA Status, and What to Know
Bremelanotide is the active compound in both the FDA-approved product Vyleesi and the compounded PT-141 formulations available at Regen Doctors. This article provides an educational overview of bremelanotide’s mechanism, its FDA-approved indication, and the important distinctions between the FDA-approved product and compounded versions. How Bremelanotide Works: The Mechanism Bremelanotide is a melanocortin receptor agonist, specifically […]